Page 10 - Read Online

Tong et al. Hepatoma Res 2019;5:36 I http://dx.doi.org/10.20517/2394-5079.2019.005 Page 5 of 13

Table 1. Baseline characteristics of 164 patients with hepatocellular carcinoma
Characteristic Number (%) or Mean ± SD
Age at diagnosis (years) 64.48 ± 10.38
Gender
Female 58 (35.4)
Male 106 (64.6)
Ethnicity
African American 6 (3.70)
Asian 105 (64.0)
Hispanic 23 (14.0)
White 30 (18.3)
Virology
HBV 65 (39.6)
HCV 98 (59.8)
HBV + HCV 1 (0.60)
HBV genotype
A 3 (4.62)
B 10 (15.4)
C 19 (29.2)
F 1 (1.54)
Missing 32 (49.2)
HBV precore mutation
Yes 15 (23.1)
No 18 (27.7)
Missing 32 (49.2)
HBV basal core promoter mutation
Yes 20 (30.8)
No 8 (12.3)
Missing 37 (56.9)
HBeAg
Negative 42 (64.6)
Positive 14 (21.5)
Missing 9 (13.8)
HBV DNA (IU/mL) * 2,411,000 (IQR: 1.00-123,400)
HCV genotype
1 45 (45.9)
2 17 (17.3)
3 6 (6.12)
6 or 7 7 (7.14)
Mixed 2 (2.04)
Missing 21 (21.4)
HCV RNA (IU/mL) * 1,442,000 (IQR: 594.5-1,270,000)
Antiviral treatment
Yes 50 (30.5)
No 108 (65.9)
Missing 6 (3.60)
Albumin (g/dL) 3.80 ± 0.66
Total bilirubin (mg/dL) 1.30 ± 1.20
Alkaline phosphate (U/L) 128 ± 129
AST (U/L) 78.2 ± 59.2
ALT (U/L) 70.1 ± 54.3
3
3
Platelet count (× 10 mm ) 138 ± 75.6
AFP (ng/mL) 45.2 ± 11.8
Surveillance
Yes 113 (68.9)
No 51 (31.1)
Diabetes
Yes 32 (19.5)
No 125 (76.2)
Missing 7 (4.27)